SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹13 Cr | ₹11 Cr | ₹8.14 Cr | ₹1.01 Cr | ₹9.37 Cr |
What is the latest Total Non-Current Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹1.01 Cr |
| Mar2021 | ₹9.37 Cr |
How is Total Non-Current Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 20.42 | |
| Mar2024 | ₹11 Cr | 33.16 | |
| Mar2023 | ₹8.14 Cr | 709.34 | |
| Mar2022 | ₹1.01 Cr | -89.26 | |
| Mar2021 | ₹9.37 Cr | - | |
Compare Total Non-Current Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹122.7 Cr | -3.9% | -18.9% | -10.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -3.9% |
-18.9% |
-10.8% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses